FDA Inspection 757323 — SRI Krishna Pharmaceuticals Ltd
The FDA completed an inspection of SRI Krishna Pharmaceuticals Ltd on Nov 17, 2011 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 17, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hyderabad (India)